1. Martin GV, Caldwell JH, Graham MM, Grierson JR, Kroll K, Cowan MJ, Lewellen TK, Rasey JS, Casciari JJ, Krohn KA. Noninvasive detection of hypoxic myocardium using fluorine-18-fluoromisonidazole and positron emission tomography. J Nucl Med 1992; 33:2202–2208.
2. Caldwell JH, Revenaugh JR, Martin GV, Johnson PM, Rasey JS, Krohn KA. Comparison of fluorine-18-fluorodeoxyglucose and tritiated fluoromisonidazole uptake during low-flow ischemia. J Nucl Med 1995; 36:1633–1638.
3. Shi CQ, Sinusas AJ, Dione DP, Singer MJ, Young LH, Heller EN, Rinker BD, Wackers FJ, Zaret BL. Technetium-99m-nitroimidazole (BMS181321): a positive imaging agent for detecting myocardial ischemia. J Nucl Med 1995; 36:1078–1086.
4. Rumsey WL, Kuczynski B, Patel B, Bauer A, Narra RK, Eaton SM, Nunn AD, Strauss HW. SPECT imaging of ischemic myocardium using a technetium-99m-nitroimidazole ligand. J Nucl Med 1995; 36:1445–1450.
5. Stone CK, Mulnix T, Nickles RJ, Renstrom B, Nellis SH, Liedtke AJ, Nunn AD, Kuczynski BL, Rumsey WL. Myocardial kinetics of a putative hypoxic tissue marker,99mTc-labeled nitroimidazole (BMS-181321), after regional ischemia and reperfusion. Circulation 1995; 92:1246–1253.